Dr. Heena Dave

Employment

• Nirma University Assistant Professor
  2024 - Present
• Nirma University Institute of Science Assistant Research Scientist
  2020 - 2024
• Nirma University Assistant Research Scientist
  2018 - 2020
• Nirma University of Science and Technology Institute of Pharmacy Visiting Faculty
  2018 - 2018
• Nirma University Institute of Science Assistant Professor
  2014 - 2017
• Nirma University Institute of Science Visiting Faculty
  2013 - 2013
• NYU Langone Medical Center Postdoctoral Fellow
  2012 - 2013
• NewYork-Presbyterian Hospital/Weill Cornell Medical Center Fulbright Nehru Doctoral & Research Scholar
  2009 - 2010
• Gujarat Cancer and Research Institute Research Assistant
  2007 - 2012
• Gujarat Cancer and Research Institute Junior Research Assistant
  1999 - 2007
• Gujarat Cancer and Research Institute Junior Research Fellow
  1996 - 1999

Education

• Ahmedabad Management Association Postgraduate Diploma in Hospital & Healthcare
  2015 - 2015
• Gujarat University PhD (Life Sciences - Cancer Research)
  2005 - 2011
• Gujarat University M.Sc (Life Sciences)
  1994 - 1996
• Gujarat University B.Sc (Biochemistry)
  1991 - 1994

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Correction to: Molecular interplay of lncRNAs, miRNAs, and mRNAs axes in triple-negative breast cancer: implications for metastatic progression
  Journal of Applied Genetics 2026 DOI: 10.1007/s13353-026-01068-5
  +Save
• Molecular interplay of lncRNAs, miRNAs, and mRNAs axes in triple-negative breast cancer: implications for metastatic progression
  Journal of Applied Genetics 2026 DOI: 10.1007/s13353-026-01061-y
  +Save
• hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis
  Biochemical and Biophysical Research Communications 2026 DOI: 10.1016/j.bbrc.2026.154342
  +Save
• Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology 2026 DOI: 10.1016/j.jsbmb.2025.106934
  +Save
• Androgen receptor as therapeutic indicator for LAR-positive triple-negative breast cancer: Preclinical and clinical assessment
  The Journal of Steroid Biochemistry and Molecular Biology 2026 DOI: 10.1016/j.jsbmb.2026.107062
  +Save
• Breast cancer: Role of microRNAs as biomarker
  Biomarker Landscape in Cancer Research 2025
  +Save
• Antagonists of CD39 and CD73 potentiate doxycycline repositioning to induce a potent antitumor immune response
  Cellular Signalling 2025 DOI: 10.1016/j.cellsig.2024.111507
  +Save
• Downregulation of miR-1269a pronounces breast cancer bone metastasis
  Human Gene 2025 DOI: 10.1016/j.humgen.2025.201380
  +Save
• 142P Implications of microRNAs in the prognostication of luminal androgen receptor-positive triple-negative breast cancer
  ESMO Open 2025 DOI: 10.1016/j.esmoop.2025.104695
  +Save
• MicroRNA-driven organ-specific metastasis in triple-negative breast cancer: biogenesis, mechanisms, and therapeutic approaches
  Medical Oncology 2025 DOI: 10.1007/s12032-025-02846-7
  +Save